Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Opinion and Comment
Nature Biotechnology 26, 27–28 (1 January 2008) | doi:10.1038/nbt0108-27b
We speak for small biotech
Abstract
Your editorial “Who speaks for small biotech?” published in the July issue highlights the difficulty of engaging small and medium-sized enterprises (SMEs) in Europe in such numbers that they are fully and individually represented. As secretary general of EuropaBio, I would like to stress that my association aims to represent in a balanced way the interests of all biotech companies, large or small; green, white or red.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
